4.6 Article

Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study

Related references

Note: Only part of the references are listed.
Letter Critical Care Medicine

Consensus on the referral and admission of patients with severe respiratory failure to the NHS ECMO service

Luigi Camporota et al.

LANCET RESPIRATORY MEDICINE (2021)

Article Engineering, Biomedical

Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization

Jenelle Badulak et al.

Summary: The guideline emphasizes the importance of ECMO treatment for COVID-19 patients, recommending the use of V-V ECMO for ARDS. More stringent contraindications should be implemented when resources are limited, and establishing regional ECMO referral networks can help expedite patient referrals.

ASAIO JOURNAL (2021)

Article Critical Care Medicine

A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation

Andrew J. Doyle et al.

Summary: This study revealed that patients with coronavirus disease 2019 receiving extracorporeal membrane oxygenation had higher rates of venous thromboembolism and hemorrhage compared to patients with influenza.

CRITICAL CARE MEDICINE (2021)

Review Hematology

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis

Xiaoming Xiong et al.

Summary: This study revealed a high prevalence of thrombosis in COVID-19 patients, especially in the ICU, indicating the importance of closely monitoring D-dimer, LDH, WBC, and lymphocyte levels.

THROMBOSIS JOURNAL (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Critical Care Medicine

Red cell alloimmunisation in patients receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO)

Deepa R. J. Arachchillage et al.

INTENSIVE CARE MEDICINE (2020)

Article Critical Care Medicine

Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations

Brijesh Patel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Letter Hematology

Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19

Deepa J. Arachchillage et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Article Critical Care Medicine

D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study

Yumeng Yao et al.

JOURNAL OF INTENSIVE CARE (2020)

Review Pharmacology & Pharmacy

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review

Lucia Gozzo et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Hematology

Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis

Stephan Nopp et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)

Article Engineering, Biomedical

Extracorporeal Life Support Organization Registry International Report 2016

Ravi R. Thiagarajan et al.

ASAIO JOURNAL (2017)

Article Medicine, General & Internal

Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1)

Moronke A. Noah et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)